Skip to main content
SpringerLink
Log in

Medikamente zur Behandlung bipolarer Störungen

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

Zusammenfassung

Die Komplexität der Behandlung bipolarer Störungen ergibt sich daraus, dass im Krankheitsverlauf sehr unterschiedliche Symptomkonstellationen auftreten können (Depression, Hypomanie, Manie, gemischte Episode, Rapid Cycling), was oft zu einer polypharmazeutischen Therapie führt. So muss mehr als bei der Behandlung jeder einzelnen Episode der langfristige Verlauf und dessen besondere polare Natur berücksichtigt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Amsterdam JD, Lorenzo-Luaces L, Soeller I et al (2015) Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: a randomized, double-blind, parallel-group, prospective study. J Affect Disord 185: 31–37

    Article  CAS  Google Scholar 

  • Berk M, Daglas R, Dandash O et al (2017) Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial. Br J Psychiatry 210(6): 413–421

    Article  Google Scholar 

  • Chang HY, Tseng PT, Stubbs B et al (2017) The efficacy and tolerability of paliperidone in mania of bipolar disorder: a preliminary meta-analysis. Exp Clin Psychopharmacol 25(5): 422–433

    Article  Google Scholar 

  • Cipriani A, Reid K, Young AH et al (2013) Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 10: CD003196

    Google Scholar 

  • Crump C, Sundquist K, Winkleby MA et al (2013) Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 70(9): 931–939

    Article  Google Scholar 

  • DGBS e.V., DGPPN e.V. (2012) S3-Leitlinie zur Diagnostik und Therapie Bipolarer Störungen. Langversion 1.0, Mai 2012

    Google Scholar 

  • El-Mallakh RS, Vöhringer PA, Ostacher MM et al (2015) Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial. J Affect Disord 184: 318–321

    Google Scholar 

  • Fountoulakis KN, Young A, Yatham L et al (2017a) The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: background and methods of the development of guidelines. Int J Neuropsychopharmacol 20(2): 98–120

    Google Scholar 

  • Fountoulakis KN, Yatham L, Grunze H (2017b) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: review, grading of the evidence, and a precise algorithm. Int J Neuropsychopharmacol 20(2): 121–179

    Google Scholar 

  • Fountoulakis KN, Grunze H, Vieta E (2017c) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: the clinical guidelines. Int J Neuropsychopharmacol 20(2): 180–195

    Google Scholar 

  • Fountoulakis KN, Vieta E, Young A et al (2017d) The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: unmet needs in the treatment of bipolar disorder and recommendations for future research. Int J Neuropsychopharmacol 20(2): 196–205

    Google Scholar 

  • Geddes JR, Gardiner A, Rendell J et al (2016) Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. Lancet Psychiatry 3(1): 31–39

    Article  Google Scholar 

  • Goodwin GM, Haddad PM, Ferrier IN et al (2016) Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol 30(6): 495–553

    Article  CAS  Google Scholar 

  • Grover S, Kukreti R (2014) HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis. Pharmacogenet Genomics 24(2): 94–112

    Article  CAS  Google Scholar 

  • Grunze H, Vieta E, Goodwin GM et al (2013) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 14(3): 154–219

    Article  Google Scholar 

  • Hiemke C, Bergemann N, Clement HW et al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1-02): 9–62

    Google Scholar 

  • Hou L, Heilbronner U, Degenhardt F et al (2016) Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet pii: S0140–6736(16)00143-4

    Google Scholar 

  • Huang RY, Hsieh KP, Huang WW et al (2016) Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. Br J Psychiatry 209(5): 393–399

    Article  Google Scholar 

  • Joas E, Karanti A, Song J (2017) Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder. Br J Psychiatry 210(3): 197–202

    Article  Google Scholar 

  • Kessing LV, Vradi E, Andersen PK (2014) Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry 205(3): 214–220

    Article  Google Scholar 

  • Kessing LV, Gerds TA, Feldt-Rasmussen B et al (2015) Lithium and renal and upper urinary tract tumors – results from a nationwide population-based study. Bipolar Disord 17(8): 805–813

    Article  CAS  Google Scholar 

  • Kessing LV, Gerds TA, Knudsen NN et al (2017) Association of lithium in drinking water with the incidence of dementia. JAMA Psychiatry 74(10): 1005–1010

    Article  Google Scholar 

  • Kessing LV, Bauer M, Nolen WA et al (2018) Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord [Epub ahead of print]

    Google Scholar 

  • Ketter TA, Miller S, Dell’Osso B, Wang PW (2016) Treatment of bipolar disorder: review of evidence regarding quetiapine and lithium. J Affect Disord 191: 256–273

    Article  CAS  Google Scholar 

  • Lähteenvuo M, Tanskanen A, Hoti F et al (2017) Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Lancet Psychiatry 4(7): 547–553

    Google Scholar 

  • Loebel A, Cucchiaro J, Silva R et al (2014) Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry 171(2): 160–168

    Article  Google Scholar 

  • Lorenzo-Luaces L, Amsterdam JD, Soeller I, DeRubeis RJ (2016) Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk. Acta Psychiatr Scand 133(6): 459–469

    Article  CAS  Google Scholar 

  • Miura T, Noma H, Furukawa TA et al (2014) Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry 1(5): 351–359

    Article  Google Scholar 

  • Pacchiarotti I, Bond DJ, Baldessarini RJ et al (2013) The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 170(11): 1249–1262

    Google Scholar 

  • Shine B, McKnight RF, Leaver L, Geddes JR (2015) Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet 386(9992): 461–468

    Article  CAS  Google Scholar 

  • Smith KA, Cipriani A (2017) Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord 19(7): 575–586

    Article  CAS  Google Scholar 

  • Stubbs B, Eggermont L, Mitchell AJ et al (2015) The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis. Acta Psychiatr Scand 131(2): 75–88

    Article  Google Scholar 

  • Szegedi A, Durgam S, Mackle M et al (2018) Randomized, double-blind, placebo-controlled trial of asenapine maintenance therapy in adults with an acute manic or mixed episode associated with bipolar I disorder. Am J Psychiatry 175(1): 71–79

    Article  Google Scholar 

  • Szmulewicz AG, Angriman F, Samamé C (2017) Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. Acta Psychiatr Scand 135(6): 527–538

    Article  CAS  Google Scholar 

  • Tohen M, McIntyre RS, Kanba S et al (2014) Efficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5. J Affect Disord 168: 136–141

    Article  CAS  Google Scholar 

  • Viktorin A, Lichtenstein P, Thase ME et al (2014) The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry 171(10): 1067–1073

    Article  Google Scholar 

  • Viktorin A, Rydén E, Thase ME et al (2017) The risk of treatment-emergent mania with methylphenidate in bipolar disorder. Am J Psychiatry 174(4): 341–348

    Article  Google Scholar 

  • Vöhringer PA, Ostacher MJ, El-Mallakh RS et al (2015) Antidepressants in type II versus type I bipolar depression: a randomized discontinuation trial. J Clin Psychopharmacol 35(5): 605–508

    Article  Google Scholar 

  • Young RC, Mulsant BH, Sajatovic M et al (2017) GERI-BD: a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. Am J Psychiatry 174(11): 1086–1093

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aachen, Deutschland

    Priv.-Doz. Dr. med. Dipl.-Kaufm. M. Paulzen

  2. Mannheim, Deutschland

    Prof. Dr. med. G. Gründer

  3. Mainz, Deutschland

    Prof. Dr. med. O. Benkert

Authors
  1. Priv.-Doz. Dr. med. Dipl.-Kaufm. M. Paulzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. G. Gründer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. O. Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to M. Paulzen , G. Gründer or O. Benkert .

Editor information

Editors and Affiliations

  1. Mainz, Deutschland

    O. Benkert

  2. München, Deutschland

    H. Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Paulzen, M., Gründer, G., Benkert, O. (2019). Medikamente zur Behandlung bipolarer Störungen. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57334-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57334-1_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57333-4

  • Online ISBN: 978-3-662-57334-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation